Who owns Cytosorbents?
- Ticker: CTSO
- CUSIP Number: 23283x206
Tip: Access positions for across all investors
Analyze quarterly positions in Cytosorbents with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Cytosorbents stock
Who bought or sold Cytosorbents this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Skylands Capital | 3.3M | $3.6M | 11% | Dec 2023 |
|
| Avenir Corporation | 3.1M | $3.4M | 12% | Dec 2023 |
|
| Vanguard Group | 1.9M | $2.2M | 0% | Dec 2023 |
|
| Neuberger Berman Group | 1.8M | $2.0M | 20% | Dec 2023 |
|
| Sargent Investment Group | 1.3M | $1.5M | 4% | Dec 2023 |
|
| CM Management | 415k | $461k | -8% | Dec 2023 |
|
| Advisor Group Holdings | 113k | $125k | -39% | Dec 2023 |
|
| Bank of America Corporation | 67k | $74k | -2% | Dec 2023 |
|
| Raymond James Financial Services Advisors | 61k | $58k | 0% | Mar 2024 |
|
| Dimensional Fund Advisors | 57k | $63k | -29% | Dec 2023 |
|
| Raymond James & Associates | 50k | $48k | 0% | Mar 2024 |
|
| Millennium Management | 45k | $50k | -73% | Dec 2023 |
|
| Stifel Financial | 45k | $50k | 100% | Dec 2023 |
|
| Key Client Fiduciary Advisors | 35k | $33k | 188% | Mar 2024 |
|
| Chicago Partners Investment | 31k | $27k | -15% | Dec 2023 |
|
| Texas Capital Bank Wealth Management Services | 31k | $34k | 0% | Dec 2023 |
|
| Bank of New York Mellon | 22k | $25k | -57% | Dec 2023 |
|
| Creative Planning | 21k | $24k | 0% | Dec 2023 |
|
| Virtu Financial | 20k | $22k | 100% | Dec 2023 |
|
| Johnson Investment Counsel | 20k | $22k | 100% | Dec 2023 |
|
| Granite Springs Asset Management | 19k | $21k | -7% | Dec 2023 |
|
| Charles Schwab Investment Management | 16k | $18k | 0% | Dec 2023 |
|
| Country Club Bank | 15k | $15k | 0% | Mar 2024 |
|
| Bradley, Foster & Sargent | 10k | $11k | 0% | Dec 2023 |
|
| Us Bancorp | 10k | $11k | 0% | Dec 2023 |
|
| Hexagon Capital Partners | 3.3k | $3.2k | 0% | Mar 2024 |
|
| UBS Group | 3.0k | $3.3k | 1403% | Dec 2023 |
|
| SOA Wealth Advisors | 2.2k | $2.1k | 0% | Mar 2024 |
|
| Advisory Services Network | 2.2k | $2.4k | 100% | Dec 2023 |
|
| Simplex Trading | 1.5k | $999.998600 | 25% | Dec 2023 |
|
| Lazard Asset Management | 938.00 | $1.0k | 100% | Dec 2023 |
|
| Wells Fargo & Company | 541.00 | $600.510000 | 3% | Dec 2023 |
|
| Jpmorgan Chase & Co | 372.00 | $412.994400 | 0% | Dec 2023 |
|
| Your Advocates | 250.00 | $278.000000 | 0% | Dec 2023 |
|
| Royal Bank of Canada | 79.00 | $0 | -99% | Dec 2023 |
|
| Hanson McClain Advisors | 37.00 | $41.998700 | 0% | Dec 2023 |
|
| Pnc Financial Services | 36.00 | $39.999600 | 100% | Dec 2023 |
|
| Bnp Paribas Arbitrage, Snc | 3.00 | $3.000000 | 0% | Dec 2023 |
|
Who sold out of Cytosorbents?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Citadel Advisors | Sep 2023 | 35k | $66k |
| Eudaimonia Partners | Sep 2023 | 24k | $44k |
| Hrt Financial | Sep 2023 | 10k | $19k |
| HighMark Wealth Management | Sep 2023 | 10k | $19k |
| Barclays | Sep 2023 | 5.6k | $10k |